ENDRA Life Sciences Inc. — Director's Dealing 2020

Jul 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2020-07-21

Reporting Person: DIGIANDOMENICO ANTHONY (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-21	Common Stock	X	100503	$0.87	Acquired	382012	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-21	Warrants	$0.87	X	100503	Disposed	2024-12-11	Common Stock (100503)	Direct

Footnotes

F1: Included unvested restricted stock units.